Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.

Lydia Zorn-Pauly,Anne Sae Lim von Stuckrad,Jens Klotsche,Thomas Rose,Tilmann Kallinich,Philipp Enghard,Lennard Ostendorf,Marie Burns,Thomas Doerner,Christian Meisel,Udo Schneider,Nadine Unterwalder,Gerd Burmester,Falk Hiepe,Tobias Alexander,Robert Biesen

Rheumatology (Oxford, England)（2022）

引用 2|浏览27

暂无评分

摘要

IFN-I pathway activation is detectable in almost all newly diagnosed SLE patients. Thus, a negative test result for SIGLEC1 is powerful to exclude SLE in suspected cases.

查看译文

关键词

CD169,SIGLEC1,SLE,biomarker,diagnosis,interferon

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要